JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nelson, E.
Right arrow Articles by O'Reilly, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, E.
Right arrow Articles by O'Reilly, I.
Journal of Pharmacology And Experimental Therapeutics, Vol. 132, Issue 1, 103-109, 1961
Copyright © 1961 by American Society for Pharmacology and Experimental Therapeutics

KINETICS OF CARBOXYTOBUTAMIDE EXCRETION FOLLOWING TOLBUTAMIDE AND CARBOXYTOLBUTAMIDE ADMINISTRATION

Eino Nelson 1 and Inge O'Reilly 1

1 School of Pharmacy, University of California Medical Center, San Francisco, California

The excretion kinetics of carboxytolbutamide after the oral ingestion of sodium tolbutamide of tolbutamide or tolbutamide free acid, intravenous injection of carboxytolbutamide and intravenous injection of sodium tolbutamide were studied in normal adult humans. Tolbutamide is nearly quantitatively oxidized in vivo to carboxytolbutamide and carboxytolbutamide is quantitatively excreted in urine. The oxidation of tolbutamide and excretion of the carboxytolbutamide formed follows the kinetics of consecutive first order processes. The mean half-life for the in vivo oxidation of tolbutamide was found to be 5.70 hours with a range of 4.4 to 6.85 hours in 14 tests with 4 subjects. The mean half-life for excretion of carboxytolbutamide was found to be 0.49 hour with a range of 0.38 to 0.56 hour in 3 tests with 3 subjects, meaning that on the average this metabolite is removed from the body about 12 times more rapidly than it is formed.

Submitted on September 22, 1960




This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
K. Ito, T. Iwatsubo, S. Kanamitsu, K. Ueda, H. Suzuki, and Y. Sugiyama
Prediction of Pharmacokinetic Alterations Caused by Drug-Drug Interactions: Metabolic Interaction in the Liver
Pharmacol. Rev., September 1, 1998; 50(3): 387 - 412.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1961 by the American Society for Pharmacology and Experimental Therapeutics.